Medicare Enrolled
Dr. James Deom, O.D., M.P.H.
Optometrist · Hazle Township, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deom from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deom?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deom
Dr. James Deom is an optometrist in Hazle Township, PA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Deom performed 7,940 Medicare services across 4,002 unique beneficiaries.
Between the years covered by Open Payments, Dr. Deom received a total of $905,093 from 47 pharmaceutical and/or device companies across 1353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deom is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 0% volume in PA
$905,093 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,940
Medicare services
Top 0% in PA for optometrist
4,002
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~722 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone lacrimal ophthalmic insert, 0.1 mg A small steroid insert placed into the tear duct to deliver medication to the eye. It is used to treat inflammation in the eye. |
1,600 | $115 | $204 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,025 | $88 | $150 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
910 | $11 | $30 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
906 | $25 | $85 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
898 | $22 | $35 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
628 | $27 | $85 |
| Insertion of drug delivery implant into tear duct A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time. |
198 | $41 | $100 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
174 | $80 | $150 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
173 | $90 | $350 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
137 | $137 | $382 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
136 | $103 | $170 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
119 | $33 | $150 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
119 | $24 | $85 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $48 | $100 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
110 | $8 | $60 |
| Dark adaptation test This test evaluates how well your eyes adjust to changes in light and dark conditions. It includes an interpretation of the results and a formal report. |
105 | $27 | $150 |
| Slit lamp examination of the eye This procedure uses a specialized microscope to examine the front portion of the eye. |
99 | $29 | $150 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
90 | $22 | $50 |
| Amniotic membrane placement on eye surface This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing. |
81 | $974 | $1,558 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
81 | $82 | $131 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
79 | $38 | $85 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
61 | $48 | $350 |
| Extended color vision testing A comprehensive eye exam that includes specialized tests to evaluate color vision. |
39 | $36 | $120 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
33 | $11 | $100 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
21 | $95 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
13.4% medium
85.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$905,093
Total received (2018-2024)
Avg $129,299/year across 7 years
Top 0% in PA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
1,353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$852,202 (94.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$46,879 (5.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,012 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$51,965
2023
$94,608
2022
$205,159
2021
$158,965
2020
$100,688
2019
$139,098
2018
$154,610
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$23,006
SUN PHARMACEUTICAL INDUSTRIES INC.
$14,338
Dompe US, Inc.
$10,015
ABBVIE INC.
$3,531
Alcon Vision LLC
$239
Mallinckrodt Hospital Products Inc.
$162
Tarsus Pharmaceuticals, Inc.
$148
Oyster Point Pharma, Inc.
$131
Glaukos Corporation
$111
CooperVision Inc.
$76
Ocular Therapeutix, Inc.
$61
BIOTISSUE HOLDINGS INC.
$54
Astellas Pharma US Inc
$28
Genentech USA, Inc.
$27
Amgen Inc.
$19
Apellis Pharmaceuticals, Inc.
$18
Top 3 companies account for 91.1% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$204,578
Allergan Inc.
$160,563
Valley Contax, Inc.
$101,174
Sun Pharmaceutical Industries Inc.
$77,135
Bausch & Lomb Americas Inc.
$52,848
Lumenis BE inc
$46,403
ABBVIE INC.
$46,131
Bausch & Lomb, a division of Bausch Health US, LLC
$39,049
Young's Valley Contax, Inc.
$39,002
SUN PHARMACEUTICAL INDUSTRIES INC.
$32,594
AbbVie Inc.
$30,295
Dompe US, Inc.
$25,770
Oyster Point Pharma, Inc.
$19,327
Lumenis, Inc
$18,500
Horizon Therapeutics plc
$2,306
Regeneron Pharmaceuticals, Inc.
$2,300
Novartis Pharmaceuticals Corporation
$1,039
Mallinckrodt Hospital Products Inc.
$1,018
Quidel Corporation
$1,000
Kala Pharmaceuticals, Inc.
$851
Alcon Vision LLC
$606
CooperVision Inc.
$422
Shire North American Group Inc
$319
Ocular Therapeutix, Inc.
$242
Sight Sciences, Inc.
$212
Johnson & Johnson Vision Care, Inc.
$149
Tarsus Pharmaceuticals, Inc.
$148
TissueTech, Inc.
$147
MacuLogix, Inc.
$140
Alcon Laboratories Inc
$139
Glaukos Corporation
$111
LKC Technologies, Inc.
$101
Optos, Inc.
$98
BIOTISSUE HOLDINGS INC.
$54
TISSUETECH, INC.
$47
Exeltis, USA Inc.
$35
BioTissue Holdings, Inc.
$31
Eyevance Pharmaceuticals LLC
$31
Astellas Pharma US Inc
$28
Genentech USA, Inc.
$27
ANI Pharmaceuticals, Inc.
$24
Amgen Inc.
$19
EyePoint Pharmaceuticals US, Inc.
$19
Apellis Pharmaceuticals, Inc.
$18
EYEVANCE PHARMACEUTICALS LLC
$18
Spark Therapeutics, Inc.
$13
Takeda Pharmaceuticals U.S.A., Inc.
$12
Top 3 companies account for 51.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALDEN SCLERAL ZENLENS · ALPHAGAN P · ALREX · Acuvue · AdaptDx · BESIVANCE · BIOTRUE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Cequa · DAILIES · DAILIES TOTAL1 · DEXTENZA · DUREZOL · DURYSTA · EYLEA · EYSUVIS · Eye Health · Flarex · INFUSE · INVELTYS · InflammaDry · Inflammadry · Izervay · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · LUXTURNA · Lumenis Pulse 120H · MIEBO · MiSight Contact Lens · MyDay Contact Lens · OCT OPHTHALMOSCOPE · OXERVATE · OptiLight · Optilight · Oxervate · PANORAMIC OPHTHALMOSCOPE · PROKERA · PURIFIED CORTROPHIN GEL · Precision 1 · Precision 7 · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · Syfovre · TEPEZZA · TOTAL30 · TRAVATAN Z · TYRVAYA · TearCare · ULTRA · VPRIV · VRAYLAR · VUITY · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · YUTIQ · Zerviate · iDose · optilight
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optometrist and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for optometrist in PA.
Geographic Context
Optometrists within 10 mi
98
Per 100K population
30.1
County median income
$62,321
Nearest hospital
LEHIGH VALLEY HOSPITAL - HAZLETON
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deom is a clinical cardiology specialist, with above-average Medicare volume (top 0% in PA), with speaking/promotional industry engagement in the top 0% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deom experienced with dexamethasone lacrimal ophthalmic insert, 0.1 mg?
Based on Medicare claims data, Dr. Deom performed 1,600 dexamethasone lacrimal ophthalmic insert, 0.1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deom receive payments from pharmaceutical companies?
Yes. Dr. Deom received a total of $905,093 from 47 companies across 1,353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deom's costs compare to other optometrists in Hazle Township?
Dr. Deom's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deom) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Optometrists in Hazle Township
Browse optometrists in Hazle Township ranked by procedure volume and transparency data.
Highest volume
Top Optometrists in PA
Optometrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Optometrists in PA
Which PA optometrists receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Valley Contax, Inc. Payments to Doctors
See all physicians who received payments from Valley Contax, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology